Process View
Any process that stops, prevents or reduces the frequency, rate or extent of response to DNA damage stimulus.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative regulation of response to dna damage stimulus"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
BCL2L1 | BCL2-like 1 | 0.986 | ||
TP53 | tumor protein p53 | 0.674 | ||
BCL2 | B-cell CLL/lymphoma 2 | 0.447 | Human | |
EP300 | E1A binding protein p300 | 0.344 | ||
THOC4 | THO complex 4 | 0.333 | ||
BCL2L11 | BCL2-like 11 (apoptosis facilitator) | 0.331 | ||
BAX | BCL2-associated X protein | 0.317 | Human | |
MSN | moesin | 0.252 | ||
USP7 | ubiquitin specific peptidase 7 (herpes virus-associated) | 0.174 | ||
TCF3 | transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) | 0.137 | ||
CDK2 | cyclin-dependent kinase 2 | 0.112 | Yeast | |
UBR1 | ubiquitin protein ligase E3 component n-recognin 1 | 0.105 | ||
ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.104 | ||
LATS2 | LATS, large tumor suppressor, homolog 2 (Drosophila) | 0.104 | ||
DDX39B | DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B | 0.100 | ||
JMJD6 | jumonji domain containing 6 | 0.094 | ||
SETD8 | SET domain containing (lysine methyltransferase) 8 | 0.093 | ||
RB1 | retinoblastoma 1 | 0.091 | ||
LAPTM5 | lysosomal protein transmembrane 5 | 0.088 | ||
CREBBP | CREB binding protein | 0.087 | ||
UBR3 | ubiquitin protein ligase E3 component n-recognin 3 (putative) | 0.080 | ||
RUNX1 | runt-related transcription factor 1 | 0.076 | ||
ESR1 | estrogen receptor 1 | 0.074 | ||
H2AFX | H2A histone family, member X | 0.073 | ||
HIPK2 | homeodomain interacting protein kinase 2 | 0.072 | ||
ARHGDIA | Rho GDP dissociation inhibitor (GDI) alpha | 0.065 | ||
HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 | 0.065 | ||
UBE2V1 | ubiquitin-conjugating enzyme E2 variant 1 | 0.064 | ||
CHEK2 | CHK2 checkpoint homolog (S. pombe) | 0.062 | ||
ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.056 | Worm | |
BAD | BCL2-associated agonist of cell death | 0.053 | ||
BAK1 | BCL2-antagonist/killer 1 | 0.053 | Human | |
KAT2B | K(lysine) acetyltransferase 2B | 0.050 | ||
HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 0.048 | ||
RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.048 | ||
SF3B2 | splicing factor 3b, subunit 2, 145kDa | 0.045 | ||
E2F1 | E2F transcription factor 1 | 0.045 | ||
CHEK1 | CHK1 checkpoint homolog (S. pombe) | 0.042 | ||
PAIP2 | poly(A) binding protein interacting protein 2 | 0.041 | ||
ATM | ataxia telangiectasia mutated | 0.040 | ||
THOC2 | THO complex 2 | 0.040 | ||
PRMT6 | protein arginine methyltransferase 6 | 0.039 | ||
WRN | Werner syndrome, RecQ helicase-like | 0.039 | ||
THOC5 | THO complex 5 | 0.038 | ||
PPP2R1A | protein phosphatase 2, regulatory subunit A, alpha | 0.038 | ||
TP53BP2 | tumor protein p53 binding protein, 2 | 0.038 | ||
EGR1 | early growth response 1 | 0.038 | ||
ZRANB1 | zinc finger, RAN-binding domain containing 1 | 0.037 | ||
LIN28B | lin-28 homolog B (C. elegans) | 0.037 | ||
SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.037 | ||
RIN1 | Ras and Rab interactor 1 | 0.035 | ||
PPP1CA | protein phosphatase 1, catalytic subunit, alpha isozyme | 0.035 | ||
SF3B1 | splicing factor 3b, subunit 1, 155kDa | 0.035 | ||
MAFA | v-maf musculoaponeurotic fibrosarcoma oncogene homolog A (avian) | 0.033 | ||
MDM4 | Mdm4 p53 binding protein homolog (mouse) | 0.033 | Human | |
MYC | v-myc myelocytomatosis viral oncogene homolog (avian) | 0.031 | ||
SMARCA4 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 | 0.031 | ||
SARNP | SAP domain containing ribonucleoprotein | 0.029 | ||
XRCC6 | X-ray repair complementing defective repair in Chinese hamster cells 6 | 0.029 | ||
CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.028 | ||
UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.028 | ||
ATR | ataxia telangiectasia and Rad3 related | 0.028 | ||
CXCR4 | chemokine (C-X-C motif) receptor 4 | 0.027 | ||
CCNT1 | cyclin T1 | 0.027 | ||
DYRK1A | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A | 0.027 | Mouse | |
SPRR2A | small proline-rich protein 2A | 0.026 | ||
USP42 | ubiquitin specific peptidase 42 | 0.026 | ||
JUB | jub, ajuba homolog (Xenopus laevis) | 0.025 | ||
RHOA | ras homolog gene family, member A | 0.025 | ||
YAP1 | Yes-associated protein 1 | 0.025 | ||
PSEN2 | presenilin 2 (Alzheimer disease 4) | 0.024 | ||
PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.023 | ||
BRCA1 | breast cancer 1, early onset | 0.023 | ||
SETD7 | SET domain containing (lysine methyltransferase) 7 | 0.023 | ||
RBBP8 | retinoblastoma binding protein 8 | 0.023 | ||
MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.022 | ||
TK1 | thymidine kinase 1, soluble | 0.022 | ||
DCAF7 | DDB1 and CUL4 associated factor 7 | 0.021 | ||
CUX1 | cut-like homeobox 1 | 0.021 | ||
ADRM1 | adhesion regulating molecule 1 | 0.021 | ||
RNR2 | l-rRNA | 0.020 | ||
UBXN1 | UBX domain protein 1 | 0.020 | ||
PSMD7 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 7 | 0.020 | ||
HNRNPM | heterogeneous nuclear ribonucleoprotein M | 0.020 | ||
SNRPD3 | small nuclear ribonucleoprotein D3 polypeptide 18kDa | 0.020 | ||
THOC1 | THO complex 1 | 0.019 | ||
STRN4 | striatin, calmodulin binding protein 4 | 0.019 | ||
GATA2 | GATA binding protein 2 | 0.019 | ||
DBN1 | drebrin 1 | 0.019 | ||
BTBD2 | BTB (POZ) domain containing 2 | 0.019 | ||
U2AF1 | U2 small nuclear RNA auxiliary factor 1 | 0.019 | ||
PSMC1 | proteasome (prosome, macropain) 26S subunit, ATPase, 1 | 0.019 | ||
UBE2B | ubiquitin-conjugating enzyme E2B (RAD6 homolog) | 0.019 | Fly | |
CLNS1A | chloride channel, nucleotide-sensitive, 1A | 0.019 | ||
HDAC1 | histone deacetylase 1 | 0.019 | ||
FANCD2 | Fanconi anemia, complementation group D2 | 0.019 | ||
CDK4 | cyclin-dependent kinase 4 | 0.019 | ||
SF3A1 | splicing factor 3a, subunit 1, 120kDa | 0.018 | ||
FBXW11 | F-box and WD repeat domain containing 11 | 0.018 | ||
MOBKL1A | MOB1, Mps One Binder kinase activator-like 1A (yeast) | 0.018 | ||
SYVN1 | synovial apoptosis inhibitor 1, synoviolin | 0.018 | ||
RAD51L3 | RAD51-like 3 (S. cerevisiae) | 0.017 | ||
NBN | nibrin | 0.017 | ||
VCAN | versican | 0.017 | ||
POLH | polymerase (DNA directed), eta | 0.017 | ||
DPP4 | dipeptidyl-peptidase 4 | 0.017 | ||
RAD51 | RAD51 homolog (RecA homolog, E. coli) (S. cerevisiae) | 0.017 | ||
ANKRD28 | ankyrin repeat domain 28 | 0.017 | ||
TP53BP1 | tumor protein p53 binding protein 1 | 0.016 | ||
CCNA2 | cyclin A2 | 0.016 | ||
HNRNPAB | heterogeneous nuclear ribonucleoprotein A/B | 0.016 | ||
AHR | aryl hydrocarbon receptor | 0.016 | ||
ZNF830 | zinc finger protein 830 | 0.016 | ||
DYRK1B | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B | 0.016 | ||
SFN | stratifin | 0.015 | ||
NME1 | non-metastatic cells 1, protein (NM23A) expressed in | 0.015 | ||
HNRNPUL1 | heterogeneous nuclear ribonucleoprotein U-like 1 | 0.015 | ||
CDC5L | CDC5 cell division cycle 5-like (S. pombe) | 0.015 | ||
UBE3A | ubiquitin protein ligase E3A | 0.015 | ||
RBM23 | RNA binding motif protein 23 | 0.015 | ||
PSMD2 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 2 | 0.015 | ||
FRA10AC1 | fragile site, folic acid type, rare, fra(10)(q23.3) or fra(10)(q24.2) candidate 1 | 0.015 | ||
PDE9A | phosphodiesterase 9A | 0.014 | ||
CTDP1 | CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) phosphatase, subunit 1 | 0.014 | ||
STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.014 | ||
BCAR1 | breast cancer anti-estrogen resistance 1 | 0.014 | ||
RNF20 | ring finger protein 20 | 0.014 | ||
UBE2S | ubiquitin-conjugating enzyme E2S | 0.014 | ||
MAGEA2 | melanoma antigen family A, 2 | 0.014 | ||
DCN | decorin | 0.014 | ||
RNF11 | ring finger protein 11 | 0.014 | ||
BRIP1 | BRCA1 interacting protein C-terminal helicase 1 | 0.014 | ||
E2F2 | E2F transcription factor 2 | 0.014 | ||
PSMD6 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 6 | 0.014 | ||
RCC1 | regulator of chromosome condensation 1 | 0.014 | ||
PSMC5 | proteasome (prosome, macropain) 26S subunit, ATPase, 5 | 0.013 | ||
CCND1 | cyclin D1 | 0.013 | ||
IGF2BP1 | insulin-like growth factor 2 mRNA binding protein 1 | 0.013 | ||
BIK | BCL2-interacting killer (apoptosis-inducing) | 0.013 | ||
USP14 | ubiquitin specific peptidase 14 (tRNA-guanine transglycosylase) | 0.013 | ||
RAD18 | RAD18 homolog (S. cerevisiae) | 0.013 | ||
MSH5 | mutS homolog 5 (E. coli) | 0.013 | ||
C17orf79 | chromosome 17 open reading frame 79 | 0.013 | ||
EZR | ezrin | 0.013 | ||
MESDC2 | mesoderm development candidate 2 | 0.013 | ||
SMARCD1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 | 0.013 | ||
RPS5 | ribosomal protein S5 | 0.013 | ||
PSMD11 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 11 | 0.012 | ||
TBC1D17 | TBC1 domain family, member 17 | 0.012 | ||
ZFYVE1 | zinc finger, FYVE domain containing 1 | 0.012 | ||
STX5 | syntaxin 5 | 0.012 | ||
LZTS2 | leucine zipper, putative tumor suppressor 2 | 0.012 | ||
PTK2 | PTK2 protein tyrosine kinase 2 | 0.012 | ||
SRGN | serglycin | 0.012 | ||
LMO2 | LIM domain only 2 (rhombotin-like 1) | 0.012 | ||
RNF144B | ring finger protein 144B | 0.012 | ||
RPL39 | ribosomal protein L39 | 0.012 | ||
PSMD4 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 4 | 0.012 | ||
MED1 | mediator complex subunit 1 | 0.012 | ||
CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.012 | ||
RAD52 | RAD52 homolog (S. cerevisiae) | 0.012 | ||
CHFR | checkpoint with forkhead and ring finger domains | 0.012 | ||
HEYL | hairy/enhancer-of-split related with YRPW motif-like | 0.012 | ||
PAAF1 | proteasomal ATPase-associated factor 1 | 0.012 | ||
GATA1 | GATA binding protein 1 (globin transcription factor 1) | 0.012 | ||
BID | BH3 interacting domain death agonist | 0.012 | ||
RYBP | RING1 and YY1 binding protein | 0.011 | ||
OTUB1 | OTU domain, ubiquitin aldehyde binding 1 | 0.011 | ||
THOC3 | THO complex 3 | 0.011 | ||
ARIH2 | ariadne homolog 2 (Drosophila) | 0.011 | ||
ABI2 | abl-interactor 2 | 0.011 | ||
RAPGEF1 | Rap guanine nucleotide exchange factor (GEF) 1 | 0.011 | ||
WDR26 | WD repeat domain 26 | 0.011 | ||
ANKRD13B | ankyrin repeat domain 13B | 0.011 | ||
EIF6 | eukaryotic translation initiation factor 6 | 0.011 | ||
SNRNP200 | small nuclear ribonucleoprotein 200kDa (U5) | 0.011 | ||
CDK9 | cyclin-dependent kinase 9 | 0.011 | ||
CSNK2B | casein kinase 2, beta polypeptide | 0.011 | ||
RBL1 | retinoblastoma-like 1 (p107) | 0.011 | ||
CHTOP | chromatin target of PRMT1 | 0.011 | ||
SF3A2 | splicing factor 3a, subunit 2, 66kDa | 0.011 | ||
HUWE1 | HECT, UBA and WWE domain containing 1 | 0.011 | ||
FAF2 | Fas associated factor family member 2 | 0.011 | ||
SF3B4 | splicing factor 3b, subunit 4, 49kDa | 0.011 | ||
E2F4 | E2F transcription factor 4, p107/p130-binding | 0.011 | ||
DAD1 | defender against cell death 1 | 0.011 | ||
SLC3A2 | solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 | 0.011 | ||
THOC6 | THO complex 6 homolog (Drosophila) | 0.011 | ||
CDK6 | cyclin-dependent kinase 6 | 0.011 | ||
ZNRF1 | zinc and ring finger 1 | 0.010 | ||
RNF40 | ring finger protein 40 | 0.010 | ||
PGAM1 | phosphoglycerate mutase 1 (brain) | 0.010 | ||
CBFA2T3 | core-binding factor, runt domain, alpha subunit 2; translocated to, 3 | 0.010 | ||
DFFA | DNA fragmentation factor, 45kDa, alpha polypeptide | 0.010 | ||
RNF168 | ring finger protein 168 | 0.010 | Human | |
MYST1 | MYST histone acetyltransferase 1 | 0.010 | ||
CCND3 | cyclin D3 | 0.010 | ||
ANXA1 | annexin A1 | 0.010 | ||
HIST2H2AC | histone cluster 2, H2ac | 0.010 | ||
FAP | fibroblast activation protein, alpha | 0.010 | ||
RFWD2 | ring finger and WD repeat domain 2 | 0.010 |